For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
DIT001
1,4-Dithia-7-azaspiro[4.4]nonane-8-carboxylic acid, (8S)-
[83552-44-7]
Hydrobromide [75776-79-3]
DOD001
Dodecanoic acid, chloromethyl ester
61413-67-0
ERY001
D-erythro-Pentonic acid, 2-deoxy-2,2-difluoro-¦Ã-lactone, 3,5-dibenzoate-
[122111-01-7]
ERY002
D-Pentonic acid, 2-deoxy-2,2-difluoro-,¦Ã-lactone
[122111-12-0]
ERY008
D-erythro-Pentofuranose, 2-deoxy-2,2-difluoro-, 1-(4-methylbenzenesulfonate) 3,5-bis(3-phenyl-2-propenoate)
[1071446-69-9]
ERY010
D-erythro-Pentonic acid, 2-deoxy-2,2-difluoro-, ¦Ã-lactone, 3,5-bis(3-phenyl-2-propenoate)
[928797-45-9]
ERY012
D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, ¦Ã-lactone, (2R)-
[879551-04-9]
ERY015
D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, ¦Ã-lactone, 3,5-di-O-benzyl-, (2R)-
ERY018
¦Á-D-erythro-Pentofuranosid-2-ulose, methyl 3,5-bis-O-(phenylmethyl)-
[885592-69-8]
ERY019
D-erythro-Pentofuranose, 2-deoxy-2-fluoro-2-methyl-, 3,5-di-O-benzyl-, (2R)-
ERY020
D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, ¦Ã-lactone, 3,5-dibenzoate, (2S)-
[1157884-58-6]
ERY021
¦Á-D-erythro-Pentofuranos-3-ulose, 5-O-[(1,1-dimethylethyl)diphenylsilyl]-1,2-O-(1-methylethylidene)-
[75783-45-8]
ERY022
¦Á-D-erythro-Pentofuranose, 3-deoxy-5-O-[(1,1-dimethylethyl)diphenylsilyl]-3-methylene-1,2-O-(1-methylethylidene)-
[179236-11-4]
EST001
Estra-1,3,5(10), 16-tetraen-3-ol
[1150-90-9]
EST003
Estra-4,9,11-trien-3-one, 17-hydroxy-, (17¦Â)-
[10161-33-8]
EST005
Estr-4-ene-3,17-dione
[734-32-7]
EST007
Estr-5(10)-ene-3,17-dione
[3962-66-1]
EST008
Estra-1,3,5(10),9(11)-tetraen-17-one, 3-hydroxy-
[1089-80-1]
EST009
Estra-1,3,5(10)-triene-3,17-diol 6-one, 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-, (7¦Á,17¦Â)-
EST009
estra-1,3,5(10)-triene-3,17-diol 6-one, 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-, (7S,13S,17S)
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help